Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Consulting agrmnt
Inv. presentation
Quarterly results
Asset acq. complete
Director departure
CC transcript
Asset disposition
Acq. announced
Protagenic Therapeutics, Inc.\new (PTIX) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/12/2016 8-K/A Entered into consulting agreement
Docs: "Audited financial statements of Protagenic Therapeutics, Inc. as of and for the years ended December 31, 2015 and 2014",
"It increases glucose import into brain cells, thus it is potentially effective against diabetes associated depression and anxiety disorders"
02/12/2016 8-K Acquisition/merger/asset purchase announced, Entered into consulting agreement
Docs: "Agreement and Plan of Merger and Reorganization, by and among Atrinsic, Inc. a Delaware corporation, Protagenic Acquisition Corp., a Delaware corporation and Protagenic Therapeutics, Inc., a Delaware corporation",
"Certificate of Merger as filed with the Delaware Secretary of State effective February 12, 2016",
"PT00114 is rapidly cleared from the patient's bloodstream (its “half life” is 5-10min if given intravenously (IV), 20-30 minutes if given subcutanesouly (SC)",
"PT00114 is rapidly cleared from the patient's bloodstream (its “half life” is 5-10min if given intravenously (IV), 20-30 minutes if given subcutanesouly (SC)",
"Form of Warrant of Protagenic Therapeutics, Inc",
"Chief Operating Officer, Interim President",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain",
"PT00114 naturally crosses the blood brain barrier, while certain other TRD drugs do not naturally do that and therefore must be given at higher doses so that any of them make it into the patient's brain"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy